DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (dorzolamide hydrochloride)
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is indicated for the treatment of Glaucoma; Ocular Hypertension.
Details
- Status
- Discontinued
- First Approved
- 2008-10-28
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Approval History
What DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Treats
2 indicationsDORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is approved for 2 conditions since its original approval in 2008. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Glaucoma
- Ocular Hypertension
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Target & Pathway
ProTarget
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Direct competitors
Same target(s) AND same indication — head-to-head.
MoA expansion candidates
Same target(s), different indications — where else is this mechanism being explored?
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE FDA Label Details
Indications & Usage
FDA Label (PDF)DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is indicated for the treatment of Glaucoma; Ocular Hypertension.
Track DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.